Mootummaan UK sirna namootni koolugaltummaa gaafatanii oliyyannoo itti galfatan irrattii fooyya'insa gochuufi. Kaayyoonsaa ...

Regeneron has reported a phase 3 win in generalized myasthenia gravis, positioning the biotech to file for FDA approval of its siRNA candidate in the increasingly competitive neuromuscular disease.

The San Diego, USA firm has simultaneously announced that the US Food and Drug Administration (FDA) has granted Orphan Drug ...

Braemar Hotels & Resorts (BHR) announced on Tuesday an upsizing of its board of directors with the appointment of Bob Ghassemieh as a new member.

Cemdisiran monotherapy, dosed subcutaneously every three months, met the primary and key secondary endpoints, showing a 2.3-point placebo-adjusted improvement in Myasthenia Gravis Activities of Daily ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it ...

The candidates are sourced from Arnatar’s next-gen RNA discovery engine, dubbed DARGER for dual-functional antisense RNA for ...

Sarepta is facing a number of issues currently, including platform-level safety concerns, management credibility issues, etc.

Arnatar is developing ART4, an antisense oligonucleotide that ups the expression of its target protein to treat a rare ...

Local farmers Craig Sirna and Chef Jamie Simpson recommend steaming corn to preserve its natural sweetness and nutrients.

The milestone payment is partially funded through Sarepta’s Arrowhead stock sale as both companies push forward with ...

Pharmaceuticals announced that the primary and key secondary endpoints were met in the Phase 3 NIMBLE trial assessing ...